Items where Author is "Rittmeyer, A."
![]() | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.
Article
Lee, S. M. and Schulz, C. and Prabhash, K. and Han, B. and Szczesna, A. and Cortinovis, D. L. and Rittmeyer, A. and Vicente Baz, D. and Califano, R. and Anh, L. Tuan and Liu, G. and Cappuzzo, F. and Reyes Contreras, J. G. and Reck, M. and Hu, Y. and Morris, S. and Hoeglander, E. K. and Connors, M. and Vollan, H. K. M. and Peters, S. (2022) IPSOS: Results from a phase III study of first-line (1L) atezolizumab (atezo) vs single-agent chemotherapy (chemo) in patients (pts) with NSCLC not eligible for a platinum-containing regimen. ANNALS OF ONCOLOGY, 33 (Suppl7). S1418-S1419. ISSN 0923-7534, 1569-8041

